Next Generation News and Research

RSS

01 Data Center applies for government funds to render broadband access to healthcare facilities in unserved areas

It was announced by 01 Data Center that it has applied to the government broadband stimulus fund to provide broadband access to healthcare facilities in the unserved areas of the US. Unserved areas exist in all 50 states because they are not connected to the internet infrastructure since most networks consider them too remote or too disperse and challenging to dig ditches and lay wires.

26 Aug 2009

2009 European Patient Monitoring Technology Leadership of the Year Award given to Mennen Medical

Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global growth consulting company Frost & Sullivan has awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award.

25 Aug 2009

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

In order to reduce the Province's greenhouse gas emissions, the BC Bioenergy Strategy is calling for greatly increased production of renewable biofuels such as ethanol, from biomass grown in BC. Two new research projects, largely funded by Genome BC, will help to answer these questions and unlock the valuable green energy found within BC's forests.

25 Aug 2009

Advanced Instruments' next-generation website facilitates easy retrieval of product and application information

Advanced Instruments has introduced a next-generation Web site that dramatically enhances the customer's online business experience when purchasing osmometers, cryoscopes, and microbiological laboratory instruments.

24 Aug 2009

Complete Genomics raises $45 million in private equity financing

Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors — Essex Woodlands Health Ventures and OrbiMed Advisors, LLC.

24 Aug 2009

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.

24 Aug 2009

Nutra Pharma launches Cobroxin for chronic pain relief

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.

21 Aug 2009

Coherex Medical raises $16.5 million from venture capital firms

Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.

21 Aug 2009

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL Diagnostics Inc. (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-Sure(TM)-- AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.

21 Aug 2009

Bayer Crop Science uses Chromatin's proprietary mini-chromosome technology

Chromatin Inc. and Bayer CropScience announced today that they have entered into a technological alliance and license agreement to use Chromatin’s proprietary mini-chromosome technology for crop improvement.

20 Aug 2009

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput screening platform for anti-microbial drug discovery.

From Fluxion Biosciences 20 Aug 2009

Patterson Companies records 6% year-on-year sales growth in first-quarter

Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson’s business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.

20 Aug 2009

3M introduces Littmann electronic stethoscope with Bluetooth

Taking the stethoscope into the 21st century, 3M today announced the introduction of the 3M™ Littmann® Electronic Stethoscope Model 3200, a next-generation auscultation device featuring Bluetooth technology that wirelessly transfers heart, lung and other body sounds to software for further analysis.

19 Aug 2009

The Gambia introduces pneumococcal immunisation programme

The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia’s Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia’s national pneumococcal immunisation programme.

19 Aug 2009

Kolltan Pharmaceuticals raises additional $5 million to close Series A financing

Kolltan Pharmaceuticals, Inc. announced today that it has raised an additional $5 million to close its Series A preferred stock financing at $40 million. Participants in the Series A financing, originally announced in January 2009, include Purdue Pharma, L.P., HBM BioCapital L.P., the Pritzker/Vlock family, and other substantial private life science investors.

19 Aug 2009

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

The University of Southern California today announced that two faculty members from the USC Viterbi School of Engineering have been recognized by Technology Review magazine as some of the world's top innovators under the age of 35. Andrea Armani, Assistant Professor of Chemical Engineering and Materials Science, and Ellis Meng, Assistant Professor of Biomedical Engineering, will both appear on the prestigious 2009 TR35 list.

19 Aug 2009

Weight training reduces lymphedema symptoms after breast cancer surgery

Breast cancer survivors who lift weights are less likely than their non-weightlifting peers to experience worsening symptoms of lymphedema, the arm- and hand-swelling condition that plagues many women following surgery for their disease, according to new University of Pennsylvania School of Medicine research published in the August 13 issue of the New England Journal of Medicine.

18 Aug 2009

Remarkable vision improvements after gene therapy for inherited blindness

One year after a trio of young adults received gene therapy for an inherited form of blindness, researchers have documented that the patients are still experiencing the same level of remarkable vision improvements previously measured within weeks.

13 Aug 2009

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

Forest Laboratories (NYSE:FRX) and AstraZeneca (NYSE:AZN) announced today they have entered into a definitive collaboration agreement to co-develop and commercialize ceftaroline in all markets outside the United States, Canada and Japan.

12 Aug 2009

New personal assistance voice dialer for seniors who need to call for help in an emergency

eMed-ID, the world's first emergency medical device franchise, announced today the launch of eMed-Alert, a next-generation personal assistance voice dialer designed for seniors who may need to call for help in an emergency. With more than 11 million Americans age 65 and older living alone today, eMed-Alert provides seniors a way to maintain their independence.

11 Aug 2009

Next Generation News and Research

01 Data Center applies for government funds to render broadband access to healthcare facilities in unserved areas

2009 European Patient Monitoring Technology Leadership of the Year Award given to Mennen Medical

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

Advanced Instruments' next-generation website facilitates easy retrieval of product and application information

Complete Genomics raises $45 million in private equity financing

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

Nutra Pharma launches Cobroxin for chronic pain relief

Coherex Medical raises $16.5 million from venture capital firms

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

Bayer Crop Science uses Chromatin's proprietary mini-chromosome technology

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Patterson Companies records 6% year-on-year sales growth in first-quarter

3M introduces Littmann electronic stethoscope with Bluetooth

The Gambia introduces pneumococcal immunisation programme

Kolltan Pharmaceuticals raises additional $5 million to close Series A financing

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

Weight training reduces lymphedema symptoms after breast cancer surgery

Remarkable vision improvements after gene therapy for inherited blindness

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

New personal assistance voice dialer for seniors who need to call for help in an emergency

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News